Blockchain Registration Transaction Record

Clene Featured in BioMedWire Podcast, CEO Discusses Novel Approach to Treating Neurodegenerative Diseases

Clene (NASDAQ: CLNN) featured in BioMedWire Podcast, CEO discusses unique approach to treating neurodegenerative diseases such as ALS and MS, highlighting potential for improved patient survival rates.

Clene Featured in BioMedWire Podcast, CEO Discusses Novel Approach to Treating Neurodegenerative Diseases

This news matters as it highlights a unique approach to treating neurodegenerative diseases such as ALS and MS, potentially improving survival rates for patients. The company’s focus on improving mitochondrial health and protecting neuronal function has significant implications for the treatment of these devastating diseases.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x91435ed33aa4ac714f3cf2f7733aebcbe3b22df15fd49883175ca49cd8a67202
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintevenh8xi-c5a73a2f0f4729146cf083fc0f6f73f7